A fluorescent benzo[g]isoquinoline-based HIF prolyl hydroxylase inhibitor for cellular imaging
Prolyl hydroxylation domain (PHD) enzymes catalyze the hydroxylation of the transcription factor hypoxia‐inducible factor (HIF) and serve as cellular oxygen sensors. HIF and the PHD enzymes regulate numerous potentially tissue‐protective target genes which can adapt cells to metabolic and ischemic s...
Príomhchruthaitheoirí: | Mayer, M, Fey, K, Heinze, E, Rainer Wick, C, Abboud, M, Yeh, T, Tumber, A, Orth, N, Schley, G, Buchholz, B, Clark, T, Schofield, C, Willam, C, Burzlaff, N |
---|---|
Formáid: | Journal article |
Foilsithe / Cruthaithe: |
Wiley
2018
|
Míreanna comhchosúla
-
No benefit of HIF prolyl hydroxylase inhibition for hypertensive renal damage in renovascular hypertensive rats
de réir: Andrea Hartner, et al.
Foilsithe / Cruthaithe: (2023-06-01) -
Tuning the transcriptional response to hypoxia by inhibiting HIF prolyl- and asparaginyl-hydroxylases
de réir: Chan, M, et al.
Foilsithe / Cruthaithe: (2016) -
Molecular and Cellular Mechanisms of HIF Prolyl Hydroxylase inhibitors in Clinical Trials
de réir: Yeh, TL, et al.
Foilsithe / Cruthaithe: (2017) -
The use of dioxygen by HIF prolyl hydroxylase (PHD1).
de réir: McNeill, L, et al.
Foilsithe / Cruthaithe: (2002) -
2-oxoglutarate analogue inhibitors of HIF prolyl hydroxylase.
de réir: Mole, D, et al.
Foilsithe / Cruthaithe: (2003)